Top Suppliers:I want be here


380380-64-3

380380-64-3 structure
380380-64-3 structure

Name 5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine
Synonyms 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine380-3
5-bromo-2-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)pyridine
5-bromo-2-(2-methyl-2H-tetrazole-5-yl)pyridine(Telizolid KRM)
Torezolid-11
Tedizolid Impurity 67
2-methyl-5-(5-bromopyridine-2-yl) tetrazolium
Ethanedioicacid,monomethylester,potassiumsalt(1:3)
2-(2-Methyl-5-tetrazolyl)-5-bromopyridine
Tedizolid impurity588
Thiazole,2-bromo-10-(bromomethyl)
Piperazine,6-(methylsulfonyl)
5-bromo-2-(2-methyltetrazol-5-yl)pyridine
Methyl-5- (5-bromo-2-yl) tetrazole
5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (Torezolid Impurity)
5-Bromo-2-(2-methyl-2H-tetrazole-5-yl)pyridine
Torezolid Intermediate2
5-BROMO-2-(2-METHYL-2H-TETRAZOL-5-YL)-PYRIDINE ISO 9001:2015 REACH
2-Methyl-5-(5-bromopyridin-2-yl)tetrazole
Pyridine, 5-broMo-2-(2-Methyl-2H-tetrazol-5-yl)
Tedizolid interMediate
5-broMo-2-(2-Methyl-2H-tetrazol-5-yl)pyridine (c)
Terazolamide impurity 12
Density 1.9±0.1 g/cm3
Boiling Point 375.2±52.0 °C at 760 mmHg
Molecular Formula C7H6BrN5
Molecular Weight 240.060
Flash Point 180.7±30.7 °C
Exact Mass 238.980652
PSA 56.49000
LogP 1.51
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.759
Hazard Codes Xi
HS Code 2933990090

~%

380380-64-3 structure

380380-64-3

Literature: ASTRAZENECA AB; ASTRAZENECA UK LIMITED Patent: WO2004/56818 A1, 2004 ; Location in patent: Page 52-53 ; WO 2004/056818 A1

~32%

380380-64-3 structure

380380-64-3

Literature: TRIUS THERAPEUTICS; COSTELLO, Carrie, A.; SIMSON, Jaqueline, A.; DUGUID, Robert, J.; PHILLIPSON, Douglas Patent: WO2010/42887 A2, 2010 ; Location in patent: Page/Page column 15-16 ;

~43%

380380-64-3 structure

380380-64-3

Literature: Im, Weon Bin; Choi, Sun Ho; Park, Ju-Young; Choi, Sung Hak; Finn, John; Yoon, Sung-Hwa European Journal of Medicinal Chemistry, 2011 , vol. 46, # 4 p. 1027 - 1039

~%

380380-64-3 structure

380380-64-3

Literature: ASTRAZENECA UK LIMITED Patent: WO2005/116023 A1, 2005 ; Location in patent: Page/Page column 67 ; WO 2005/116023 A1

~%

380380-64-3 structure

380380-64-3

Literature: Clark, Richard F.; Djuric, Stevan; Ma, Zhenkun; Phan, Ly; Rupp, Michael Patent: US2004/33970 A1, 2004 ; Location in patent: Page/Page column 9 ;

~%

380380-64-3 structure

380380-64-3

Literature: Jo, Yeong Woo; Im, Weon Bin; Rhee, Jae Keol; Shim, Mi Ja; Kim, Won Bae; Choi, Eung Chil Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 22 p. 5909 - 5915

~%

380380-64-3 structure

380380-64-3

Literature: Im, Weon Bin; Choi, Sun Ho; Park, Ju-Young; Choi, Sung Hak; Finn, John; Yoon, Sung-Hwa European Journal of Medicinal Chemistry, 2011 , vol. 46, # 4 p. 1027 - 1039

~%

380380-64-3 structure

380380-64-3

Literature: Im, Weon Bin; Choi, Sun Ho; Park, Ju-Young; Choi, Sung Hak; Finn, John; Yoon, Sung-Hwa European Journal of Medicinal Chemistry, 2011 , vol. 46, # 4 p. 1027 - 1039
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.